AL Amyloidosis - 146 Studies Found
| Recruiting |
: Daratumumab Therapy for Patients With Refractory or Relapsed AL Amyloidosis : Amyloidosis : 2016-06-22 : Drug: Daratumumab |
| Recruiting |
: Study of Chimeric Fibril-Reactive Monoclonal Antibody 11-1F4 in Patients With AL Amyloidosis : Amyloidosis : 2014-09-15 : Drug: Chimeric Fibril-Reactive Monoclonal Anti-body 11-1F4 The antibody binds to the pathologic material |
| Completed |
: Cyclophosphamide, Lenalidomide and Dexamethasone (CLD) for Previously Treated Patients With AL Amyloidosis : Amyloidosis : 2008-01-22 :
|
| Not yet recruiting |
: Propylene Glycol-Free Melphalan Hydrochloride (Evomela) in AL Amyloidosis Patients : Amyloidosis; Systemic : 2016-11-18 : Drug: Propylene Glycol-Free Melphalan Hydrochloride Intravenous Propylene Glycol-Free Melphalan Hydrochl |
| Completed |
: Intensive Versus Conventional Treatment in Patients With Primary Amyloidosis : Primary Systemic Amyloidosis (AL) : 2006-06-22 :
|
| Active, not recruiting |
: Bortezomib/Dexamethasone (BD), Followed By Autologous Stem Cell Transplantation and Maintenance Bortezomib/Dexamethasone For the Initial Treatment of Monoclonal Immunoglobulin Deposition Disease (MIDD) Associated With Multiple Myeloma and AL Amyloidosis :
|
| Completed |
: S9628 Dexamethasone Plus Interferon Alfa in Treating Patients With Primary Systemic Amyloidosis : Multiple Myeloma : 1999-11-01 :
|
| Completed |
: CC-5013 With or Without Dexamethasone in Treating Patients With Primary Systemic Amyloidosis : Multiple Myeloma : 2004-09-07 :
|
| Suspended |
: Phase II Trial of Enbrel in Patients With Primary Systemic Amyloidosis : Primary Systemic Amyloidosis : 2005-09-21 : Drug: Enbrel |
| Completed |
: Melphalan, Lenalidomide, and Dexamethasone in Treating Patients With Primary Systemic Amyloidosis : Multiple Myeloma : 2008-05-14 :
|